کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
3001912 1180685 2015 8 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Association of plasma small dense LDL cholesterol with PCSK9 levels in patients with angiographically proven coronary artery disease
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی کاردیولوژی و پزشکی قلب و عروق
پیش نمایش صفحه اول مقاله
Association of plasma small dense LDL cholesterol with PCSK9 levels in patients with angiographically proven coronary artery disease
چکیده انگلیسی


• PCSK9 is a major regulator of LDL metabolism and cholesterol homeostasis.
• sdLDL has been suggested to be very atherogenic subspecies of LDL.
• SdLDL-C was related to PCSK9 in patients with stable CAD but not in non-CAD.
• There may be an interaction between sdLDL-C and PCSK9 in atherosclerotic status.

Background and aimsProprotein convertase subtilisin–kexin type 9 (PCSK9) is a novel regulator of low-density lipoprotein (LDL) metabolism. Recently, small dense LDL (sdLDL) particles have been suggested to be a very atherogenic subspecies of LDL. To date, the association of sdLDL with PCSK9 is still unclear. The aim of the present study is to determine the association of sdLDL, as assayed by sdLDL-cholesterol (sdLDL-C), with PCSK9 in a cohort of subjects undergoing coronary angiography.Methods and resultsFour hundred and ninety consecutive subjects were enrolled and classified into stable coronary artery disease (CAD) and non-CAD group. LDL separation was performed by Lipoprint System: 7 LDL subfractions were obtained and LDL score (% sdLDL) was calculated. The plasma PCSK9 levels were measured by ELISA. The data indicated that PCSK9 levels were significantly increased by sdLDL-C quartiles (p = 0.028). In age- and sex-adjusted analysis plasma sdLDL-C was positively correlated with PCSK9 levels (r = 0.157, p < 0.01). To rule out the confounding effect of dyslipidemia, we performed the analysis in subjects with and without dyslipidemia separately. Interestingly, the positive correlation of sdLDL-C with PCSK9 was only significant in patients with dyslipidemia and stable CAD (r = 0.177, p < 0.01). In a model adjusting for traditional risk factors including dyslipidemia, PCSK9 was an independent predictor of high sdLDL-C in CAD group (OR = 12.919, 95% CI 1.427–116.952) but not in non-CAD group.ConclusionThis study firstly demonstrated that plasma sdLDL-C was positively related to PCSK9 in patients with stable CAD, suggesting an interaction between sdLDL-C and PCSK9 in atherosclerotic coronary disease.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Nutrition, Metabolism and Cardiovascular Diseases - Volume 25, Issue 4, April 2015, Pages 426–433
نویسندگان
, , , , , , ,